Pharma's Big Data Deals
Executive Summary
Pharma is seeking Big Data's assistance in many stages of the cancer drug discovery and development process. A look at some recent collaborations.
You may also be interested in...
Oncology Disruption Demands Strategic Transformation
The rapidly accelerating complexity of oncology drug development demands a new way of doing business. To succeed in this new landscape, biopharma companies must transform their portfolios and partnerships, and shift toward more dynamic business and operating models and decision-making processes.